New MSF report exposes pharma industry failings and highlights new ways of researching and developing medicines that address public health needs.

Ise-Shima, Japan/Geneva May 26, 2016 - Two years since the first signs of the West Africa Ebola outbreak, the world today is little more prepared to respond to such an emergency than it was then, warns international humanitarian aid organisation Médecins Sans Frontières (MSF), while the lack of R&D into needed medicines and exorbitant medicine prices requires urgent and united action from the world leaders gathered in Japan.

Médecins Sans Frontières (MSF) released a report that outlines shortcomings of the current system for new drug development. The report highlights resulting access barriers and proposes policy solutions.

New Delhi, 23 March 2016 - The Indian Government recently responded to media reports that they had assured the US India Business Council that they would not grant compulsory licences on medicines - overriding a patent to allow for the production of affordable generic versions of medicines under licence - in the future.

Médecins Sans Frontières released the 4th edition of its report DR-TB Drugs Under the Microscope. The report analyzes the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis.

19 February 2016 - MSF appreciates Otsuka Pharmaceuticals’ donation of 400 treatments of a novel drug, delamanid, which enables MSF and its partners to initially treat a specific number of MDR-TB patients worldwide.

Médecins Sans Frontières calls for companies to make new drugs to treat drug-resistant TB, bedaquiline and delamanid, available and affordable.

Urgent phase-out needed for outdated policies of mandatory hospitalisation, re-treatment regimens that contribute to drug resistance, and sub-optimal diagnosis.

2015 Union World Conference on Lung Health, Cape Town, South Africa
Date: December 4, 2015
Time: 17h15-18h30

5 November 2015 - The Trans-Pacific Partnership (TPP) is a trade agreement negotiated between the U.S. and eleven other Pacific Rim nations: Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam. After more than five years of negotiations conducted in secret without the opportunity for public review, the agreed text, which will now be submitted to national processes for final signature and ratification, has been officially and publicly released. Doctors Without Borders/Médecins Sans Frontières (MSF) remains extremely concerned about the inclusion of dangerous provisions that would dismantle public health safeguards enshrined in international law and restrict access to price-lowering generic medicines for millions of people.